Soleno Therapeutics, Inc.
SLNO
$52.95
$0.020.04%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 171.68% | 177.45% | 133.95% | 78.46% | -104.57% |
| Total Depreciation and Amortization | 1.98% | 1.19% | 0.40% | 1.62% | 2.86% |
| Total Amortization of Deferred Charges | 0.00% | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2.52% | -61.07% | -81.37% | 29.06% | 161.84% |
| Change in Net Operating Assets | -251.79% | -345.88% | 18.88% | -355.42% | -427.80% |
| Cash from Operations | 179.32% | 303.01% | 391.13% | 28.57% | -161.43% |
| Capital Expenditure | -700.00% | -625.00% | 99.48% | -12.50% | 54.55% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 65.74% | -2,042.37% | -2,261.24% | 93.46% | 119.91% |
| Cash from Investing | 65.60% | -2,045.68% | -2,363.44% | 93.45% | 119.90% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -98.41% | -86.70% | 9,481.36% | -89.59% | 249.68% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1,658.06% | -- | -- | -- | -- |
| Cash from Financing | -132.41% | -275.07% | 9,489.19% | -89.73% | 243.07% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,053.77% | -546.81% | 2,076.14% | -134.10% | 94.80% |